Valuation: Pfizer Inc.

Capitalization 156B 132B 122B 115B 214B 14,520B 219B 1,426B 561B 6,947B 584B 571B 24,762B P/E ratio 2026 *
12.4x
P/E ratio 2027 * 13.4x
Enterprise value 201B 171B 158B 149B 278B 18,795B 283B 1,846B 726B 8,992B 755B 739B 32,052B EV / Sales 2026 *
3.28x
EV / Sales 2027 * 3.34x
Free-Float
59.04%
Yield 2026 *
6.43%
Yield 2027 * 6.42%
1 day-0.29%
1 week-3.46%
Current month-2.64%
1 month+1.79%
3 months+8.19%
6 months+10.33%
Current year+9.80%
1 week 26.68
Extreme 26.68
27.68
1 month 26.44
Extreme 26.44
28.74
Current year 24.83
Extreme 24.83
28.74
1 year 21.87
Extreme 21.87
28.74
3 years 20.92
Extreme 20.915
41.71
5 years 20.92
Extreme 20.915
61.71
10 years 20.92
Extreme 20.915
61.71
Manager TitleAgeSince
Chief Executive Officer 64 2018-12-31
Director of Finance/CFO 61 2022-05-01
Chief Tech/Sci/R&D Officer - 2025-02-23
Director TitleAgeSince
Director/Board Member 68 2007-08-31
Director/Board Member 62 2013-09-26
Chairman 64 2019-12-31
Change 5d. change 1-year change 3-years change Capi.($)
+1.56%-3.46%+24.78%-33.91% 153B
-1.06%-0.64%+26.92%+151.88% 841B
-0.21%-2.09%+56.83%+45.17% 574B
-0.71%-1.13%+17.95%+27.17% 368B
-0.35%-0.75%+29.45%+14.60% 320B
-1.59%-2.14%+49.76%+26.78% 318B
-1.05%-0.60%+51.74%+5.63% 300B
-0.94%-2.09%+40.11%+39.04% 295B
-0.34%+0.54%+22.32%+40.21% 189B
+0.03%-0.49%+34.16%+69.22% 173B
Average -0.33%-0.85%+35.40%+38.58% 353.1B
Weighted average by Cap. -0.24%-0.62%+36.36%+57.88%

Financials

2026 *2027 *
Net sales 61.3B 52.1B 48.02B 45.36B 84.51B 5,723B 86.33B 562B 221B 2,738B 230B 225B 9,761B 58.88B 50.04B 46.12B 43.57B 81.17B 5,497B 82.91B 540B 212B 2,630B 221B 216B 9,375B
Net income 12.04B 10.23B 9.43B 8.91B 16.59B 1,124B 16.95B 110B 43.44B 538B 45.17B 44.2B 1,917B 11.59B 9.85B 9.08B 8.57B 15.97B 1,082B 16.32B 106B 41.81B 517B 43.48B 42.54B 1,845B
Net Debt 45.78B 38.91B 35.86B 33.88B 63.12B 4,274B 64.47B 420B 165B 2,045B 172B 168B 7,290B 40.97B 34.83B 32.09B 30.32B 56.48B 3,825B 57.7B 376B 148B 1,830B 154B 150B 6,524B
Logo Pfizer Inc.
Pfizer, Inc. is the world's leading pharmaceutical group. Net sales break down by family of products as follows: - primary care products (47.4%): medicines used in internal medicine, vaccines, medicines for the prevention and treatment of Covid-19, antivirals, mRNA-based products, etc.; - specialty care products (26.2%): medicines used in immunology, in hospitals and for the treatment of rare diseases, anti-inflammatory medicines, etc.; - oncology products (24.5%); - other (1.9%). The United States accounts for 60.8% of net sales.
Employees
75,000
Date Price Change Volume
26-04-13 27.34 $ +1.56% 43,994,850
26-04-10 26.92 $ -1.10% 27,882,376
26-04-09 27.22 $ -0.91% 27,047,559
26-04-08 27.47 $ +1.37% 33,789,069
26-04-07 27.10 $ -2.62% 46,620,512
Trader
Investor
Global
Quality
ESG MSCI
A
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
28
Last Close Price
27.34USD
Average target price
28.81USD
Spread / Average Target
+5.38%

Quarterly revenue - Rate of surprise